Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.02890355 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.02890355 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.88667870 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.78747878 |
5 | negative thymic T cell selection (GO:0045060) | 4.50568729 |
6 | negative T cell selection (GO:0043383) | 4.44291934 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42185163 |
8 | immunoglobulin mediated immune response (GO:0016064) | 4.33907004 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00196137 |
10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.93704042 |
11 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.92854411 |
12 | positive thymic T cell selection (GO:0045059) | 3.87643608 |
13 | response to interleukin-15 (GO:0070672) | 3.69407468 |
14 | thymic T cell selection (GO:0045061) | 3.61604016 |
15 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.52049051 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.51653834 |
17 | modulation by symbiont of host defense response (GO:0052031) | 3.51653834 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.51653834 |
19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.51653834 |
20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.51653834 |
21 | modulation by symbiont of host immune response (GO:0052553) | 3.51653834 |
22 | response to protozoan (GO:0001562) | 3.49039396 |
23 | NIK/NF-kappaB signaling (GO:0038061) | 3.48492085 |
24 | leukocyte aggregation (GO:0070486) | 3.47628442 |
25 | T-helper 1 type immune response (GO:0042088) | 3.42667226 |
26 | B cell mediated immunity (GO:0019724) | 3.41975186 |
27 | negative regulation of interleukin-12 production (GO:0032695) | 3.38550164 |
28 | defense response to protozoan (GO:0042832) | 3.36878134 |
29 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.35423557 |
30 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34279237 |
31 | cellular response to interleukin-15 (GO:0071350) | 3.32405583 |
32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32260754 |
33 | regulation of T cell tolerance induction (GO:0002664) | 3.32226276 |
34 | tolerance induction (GO:0002507) | 3.30491314 |
35 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.28252469 |
36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27928228 |
37 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.27314750 |
38 | regulation of antigen processing and presentation (GO:0002577) | 3.26112405 |
39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.23042968 |
40 | response to peptidoglycan (GO:0032494) | 3.22575173 |
41 | positive regulation of B cell differentiation (GO:0045579) | 3.21237914 |
42 | ATP synthesis coupled proton transport (GO:0015986) | 3.18021221 |
43 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.18021221 |
44 | detection of bacterium (GO:0016045) | 3.17956043 |
45 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.16768717 |
46 | response to interferon-beta (GO:0035456) | 3.16010019 |
47 | T cell selection (GO:0045058) | 3.13516619 |
48 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.13365292 |
49 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11531960 |
50 | cellular response to interferon-beta (GO:0035458) | 3.04954636 |
51 | interferon-gamma production (GO:0032609) | 3.04658130 |
52 | viral transcription (GO:0019083) | 3.03609296 |
53 | negative regulation of B cell apoptotic process (GO:0002903) | 3.02087299 |
54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01628615 |
55 | T cell costimulation (GO:0031295) | 2.99892206 |
56 | detection of other organism (GO:0098543) | 2.99767641 |
57 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96255840 |
58 | regulation of cholesterol homeostasis (GO:2000188) | 2.94571102 |
59 | lymphocyte costimulation (GO:0031294) | 2.94127608 |
60 | positive T cell selection (GO:0043368) | 2.93477170 |
61 | germinal center formation (GO:0002467) | 2.90841447 |
62 | growth hormone receptor signaling pathway (GO:0060396) | 2.89949908 |
63 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88953121 |
64 | B cell receptor signaling pathway (GO:0050853) | 2.88892435 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.87831014 |
66 | positive regulation of humoral immune response (GO:0002922) | 2.87134653 |
67 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.86495961 |
68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.86446721 |
69 | L-phenylalanine catabolic process (GO:0006559) | 2.86446721 |
70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.82485994 |
71 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82139159 |
72 | sequestering of actin monomers (GO:0042989) | 2.82077316 |
73 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81306903 |
74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81306903 |
75 | positive regulation of interleukin-2 production (GO:0032743) | 2.80919603 |
76 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.80202230 |
77 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.80202230 |
78 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80099882 |
79 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.79624316 |
80 | regulation of B cell apoptotic process (GO:0002902) | 2.79176643 |
81 | cytidine metabolic process (GO:0046087) | 2.75461196 |
82 | cytidine catabolic process (GO:0006216) | 2.75461196 |
83 | cytidine deamination (GO:0009972) | 2.75461196 |
84 | translational termination (GO:0006415) | 2.74924166 |
85 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73556157 |
86 | L-phenylalanine metabolic process (GO:0006558) | 2.72785184 |
87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.72785184 |
88 | macrophage activation involved in immune response (GO:0002281) | 2.72520519 |
89 | DNA deamination (GO:0045006) | 2.72501523 |
90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.72124338 |
91 | negative regulation of cell killing (GO:0031342) | 2.72124338 |
92 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.71822652 |
93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70759039 |
94 | positive regulation of lymphocyte migration (GO:2000403) | 2.70544602 |
95 | T cell migration (GO:0072678) | 2.70314517 |
96 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.68839868 |
97 | valine metabolic process (GO:0006573) | 2.68385100 |
98 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.68350688 |
99 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.68259699 |
100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68100680 |
101 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.65977540 |
102 | cellular response to interferon-gamma (GO:0071346) | 2.65570522 |
103 | T cell receptor signaling pathway (GO:0050852) | 2.65381056 |
104 | respiratory burst (GO:0045730) | 2.64516311 |
105 | neutrophil activation involved in immune response (GO:0002283) | 2.64348941 |
106 | positive regulation of tolerance induction (GO:0002645) | 2.64308104 |
107 | regulation of B cell differentiation (GO:0045577) | 2.62918117 |
108 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.62907121 |
109 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.62876274 |
110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.62762281 |
111 | myeloid dendritic cell differentiation (GO:0043011) | 2.62678000 |
112 | positive regulation of defense response to virus by host (GO:0002230) | 2.62590861 |
113 | regulation of lymphocyte migration (GO:2000401) | 2.60433595 |
114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.59782506 |
115 | response to host immune response (GO:0052572) | 2.59782506 |
116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59380074 |
117 | regulation of tolerance induction (GO:0002643) | 2.58964128 |
118 | regulation of response to interferon-gamma (GO:0060330) | 2.58745566 |
119 | positive regulation of prostaglandin secretion (GO:0032308) | 2.58640206 |
120 | amyloid precursor protein catabolic process (GO:0042987) | 2.58472472 |
121 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58245314 |
122 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.57662811 |
123 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.55005246 |
124 | positive regulation of B cell activation (GO:0050871) | 2.54022836 |
125 | positive regulation of interleukin-10 production (GO:0032733) | 2.53779106 |
126 | negative regulation of innate immune response (GO:0045824) | 2.53645381 |
127 | positive regulation of B cell proliferation (GO:0030890) | 2.52815575 |
128 | positive regulation of interferon-gamma production (GO:0032729) | 2.52606782 |
129 | positive regulation of DNA recombination (GO:0045911) | 2.51973721 |
130 | hepatocyte apoptotic process (GO:0097284) | 2.51756533 |
131 | response to type I interferon (GO:0034340) | 2.51371819 |
132 | leukocyte cell-cell adhesion (GO:0007159) | 2.51360278 |
133 | positive regulation of cell killing (GO:0031343) | 2.50089138 |
134 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.49621468 |
135 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48866865 |
136 | cellular response to growth hormone stimulus (GO:0071378) | 2.47109047 |
137 | regulation of immunoglobulin secretion (GO:0051023) | 2.46562126 |
138 | myeloid dendritic cell activation (GO:0001773) | 2.45734809 |
139 | type I interferon signaling pathway (GO:0060337) | 2.45349107 |
140 | cellular response to type I interferon (GO:0071357) | 2.45349107 |
141 | response to muramyl dipeptide (GO:0032495) | 2.43787485 |
142 | negative regulation of sterol transport (GO:0032372) | 2.43176277 |
143 | negative regulation of cholesterol transport (GO:0032375) | 2.43176277 |
144 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.42602248 |
145 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.41255596 |
146 | regulation of cell killing (GO:0031341) | 2.40823147 |
147 | myelin maintenance (GO:0043217) | 2.39573424 |
148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.38417899 |
149 | protein-lipid complex assembly (GO:0065005) | 2.38174479 |
150 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.37971446 |
151 | Peyers patch development (GO:0048541) | 2.37971446 |
152 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.36943206 |
153 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.35527926 |
154 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.35527926 |
155 | regulation of natural killer cell differentiation (GO:0032823) | 2.35253228 |
156 | regulation of memory T cell differentiation (GO:0043380) | 2.35101819 |
157 | positive regulation of isotype switching (GO:0045830) | 2.34302446 |
158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34203772 |
159 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.32035162 |
160 | positive regulation of B cell mediated immunity (GO:0002714) | 2.32035162 |
161 | aromatic amino acid family catabolic process (GO:0009074) | 2.31809972 |
162 | T-helper cell differentiation (GO:0042093) | 2.31013844 |
163 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.31013844 |
164 | creatine metabolic process (GO:0006600) | 2.30345257 |
165 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.30231186 |
166 | regulation of extracellular matrix disassembly (GO:0010715) | 2.30102461 |
167 | positive regulation of immunoglobulin production (GO:0002639) | 2.28380460 |
168 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.28336012 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.82857569 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94885894 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.88752674 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85556822 |
5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04358744 |
6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.89733139 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.86505520 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82437637 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.68858601 |
10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58417407 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.51268459 |
12 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44441626 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44106374 |
14 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.43184146 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42526141 |
16 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39065559 |
17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.33176670 |
18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30764119 |
19 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26141595 |
20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24351882 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18181143 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 2.13137185 |
23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11643833 |
24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.10480518 |
25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09791830 |
26 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08928525 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08233638 |
28 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.06080074 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04340745 |
30 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92144635 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91958861 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91540198 |
33 | MYC_22102868_ChIP-Seq_BL_Human | 1.90243418 |
34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.86683234 |
35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80776036 |
36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.79165620 |
37 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.78715726 |
38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.77418315 |
39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76733987 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75852226 |
41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75193224 |
42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74525896 |
43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73274508 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72808512 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72482001 |
46 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71962577 |
47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.69210414 |
48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66687264 |
49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.66125885 |
50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65913443 |
51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.65115856 |
52 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63597889 |
53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62939684 |
54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.59490021 |
55 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.59431793 |
56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56692275 |
57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53099115 |
58 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.51460433 |
59 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.49526326 |
60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48311469 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.47824961 |
62 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45403201 |
63 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.45038025 |
64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44357577 |
65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44241500 |
66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42615754 |
67 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41820542 |
68 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41797298 |
69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.41617851 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.41244822 |
71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40739863 |
72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40735387 |
73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40043444 |
74 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38460403 |
75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37897531 |
76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37777382 |
77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36485585 |
78 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.34216939 |
79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30838677 |
80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30556155 |
81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29766496 |
82 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28740718 |
83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27449295 |
84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26016361 |
85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25840910 |
86 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25389736 |
87 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23316760 |
88 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22475560 |
89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21800924 |
90 | * P300_27268052_Chip-Seq_Bcells_Human | 1.21762071 |
91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20799038 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19865783 |
93 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.19338962 |
94 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18895595 |
95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17314500 |
96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16284253 |
97 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.15913797 |
98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15659010 |
99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14444854 |
100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14119811 |
101 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.13411017 |
102 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13249345 |
103 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.12410580 |
104 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11944510 |
105 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11743439 |
106 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11606907 |
107 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.10979342 |
108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10885833 |
109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10726399 |
110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10650287 |
111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10595152 |
112 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10250596 |
113 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09708831 |
114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09586521 |
115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09509223 |
116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09370816 |
117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07503906 |
118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06698098 |
119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05869613 |
120 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05785576 |
121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05736936 |
122 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05597593 |
123 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05431949 |
124 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05378159 |
125 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04657394 |
126 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04626141 |
127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03858176 |
128 | P68_20966046_ChIP-Seq_HELA_Human | 1.03652039 |
129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03132807 |
130 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02905675 |
131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02897338 |
132 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02887338 |
133 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02493449 |
134 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02004439 |
135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98837512 |
136 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98453325 |
137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.97671632 |
138 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97513469 |
139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95804607 |
140 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95428221 |
141 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93486860 |
142 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.92638429 |
143 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92459918 |
144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92360400 |
145 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92316578 |
146 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91075076 |
147 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91047258 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000685_abnormal_immune_system | 3.57131132 |
2 | MP0005671_abnormal_response_to | 2.91706328 |
3 | MP0001835_abnormal_antigen_presentation | 2.88849406 |
4 | MP0005360_urolithiasis | 2.87061489 |
5 | MP0002139_abnormal_hepatobiliary_system | 2.78419944 |
6 | MP0003763_abnormal_thymus_physiology | 2.72745687 |
7 | MP0001790_abnormal_immune_system | 2.58569219 |
8 | MP0005387_immune_system_phenotype | 2.58569219 |
9 | MP0003300_gastrointestinal_ulcer | 2.55700037 |
10 | MP0006082_CNS_inflammation | 2.49936159 |
11 | MP0009785_altered_susceptibility_to | 2.47353816 |
12 | MP0001873_stomach_inflammation | 2.46547902 |
13 | MP0003436_decreased_susceptibility_to | 2.33730087 |
14 | MP0002138_abnormal_hepatobiliary_system | 2.27755310 |
15 | MP0001800_abnormal_humoral_immune | 2.25920761 |
16 | MP0005000_abnormal_immune_tolerance | 2.24339975 |
17 | MP0009840_abnormal_foam_cell | 2.22071914 |
18 | MP0003724_increased_susceptibility_to | 2.11678576 |
19 | MP0004947_skin_inflammation | 2.06652079 |
20 | MP0002254_reproductive_system_inflammat | 2.06061696 |
21 | MP0010155_abnormal_intestine_physiology | 2.02639375 |
22 | MP0002723_abnormal_immune_serum | 2.00531865 |
23 | MP0005025_abnormal_response_to | 1.99923605 |
24 | MP0005365_abnormal_bile_salt | 1.99861468 |
25 | MP0002166_altered_tumor_susceptibility | 1.93165189 |
26 | MP0002405_respiratory_system_inflammati | 1.90187680 |
27 | MP0009278_abnormal_bone_marrow | 1.89675954 |
28 | MP0002452_abnormal_antigen_presenting | 1.85496939 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.84326686 |
30 | MP0002420_abnormal_adaptive_immunity | 1.83854011 |
31 | MP0001819_abnormal_immune_cell | 1.82786768 |
32 | MP0005085_abnormal_gallbladder_physiolo | 1.82099329 |
33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77328481 |
34 | MP0003866_abnormal_defecation | 1.76778815 |
35 | MP0002148_abnormal_hypersensitivity_rea | 1.75261408 |
36 | MP0003303_peritoneal_inflammation | 1.70019238 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.69981755 |
38 | MP0000343_altered_response_to | 1.69929054 |
39 | MP0002419_abnormal_innate_immunity | 1.69044800 |
40 | MP0001845_abnormal_inflammatory_respons | 1.66165619 |
41 | MP0002277_abnormal_respiratory_mucosa | 1.65585336 |
42 | MP0002933_joint_inflammation | 1.64445220 |
43 | MP0004510_myositis | 1.59366050 |
44 | MP0001666_abnormal_nutrient_absorption | 1.57837431 |
45 | MP0003252_abnormal_bile_duct | 1.56540514 |
46 | MP0002398_abnormal_bone_marrow | 1.53045158 |
47 | MP0010234_abnormal_vibrissa_follicle | 1.51975229 |
48 | MP0000716_abnormal_immune_system | 1.51468994 |
49 | MP0003806_abnormal_nucleotide_metabolis | 1.51214729 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.48452883 |
51 | MP0005464_abnormal_platelet_physiology | 1.47934978 |
52 | MP0009379_abnormal_foot_pigmentation | 1.44755947 |
53 | MP0005310_abnormal_salivary_gland | 1.40935973 |
54 | MP0008469_abnormal_protein_level | 1.40132061 |
55 | MP0005058_abnormal_lysosome_morphology | 1.39256174 |
56 | MP0000609_abnormal_liver_physiology | 1.37850095 |
57 | MP0001533_abnormal_skeleton_physiology | 1.37728062 |
58 | MP0009643_abnormal_urine_homeostasis | 1.35809948 |
59 | MP0002006_tumorigenesis | 1.32321135 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.32116029 |
61 | MP0000689_abnormal_spleen_morphology | 1.30307662 |
62 | MP0002722_abnormal_immune_system | 1.29832600 |
63 | MP0001853_heart_inflammation | 1.27881324 |
64 | MP0000604_amyloidosis | 1.27782057 |
65 | MP0003172_abnormal_lysosome_physiology | 1.24935505 |
66 | MP0002429_abnormal_blood_cell | 1.22887259 |
67 | MP0002653_abnormal_ependyma_morphology | 1.18480073 |
68 | MP0005166_decreased_susceptibility_to | 1.18089180 |
69 | MP0010329_abnormal_lipoprotein_level | 1.17632738 |
70 | MP0005083_abnormal_biliary_tract | 1.16800188 |
71 | MP0009764_decreased_sensitivity_to | 1.15465874 |
72 | MP0002132_abnormal_respiratory_system | 1.15415923 |
73 | MP0000465_gastrointestinal_hemorrhage | 1.13251747 |
74 | MP0001851_eye_inflammation | 1.10444672 |
75 | MP0002136_abnormal_kidney_physiology | 1.09174694 |
76 | MP0005332_abnormal_amino_acid | 1.09159914 |
77 | MP0000703_abnormal_thymus_morphology | 1.06470729 |
78 | MP0003011_delayed_dark_adaptation | 1.03404617 |
79 | MP0000490_abnormal_crypts_of | 1.02013911 |
80 | MP0001348_abnormal_lacrimal_gland | 1.00887323 |
81 | MP0003195_calcinosis | 1.00326553 |
82 | MP0004019_abnormal_vitamin_homeostasis | 0.96126359 |
83 | MP0000858_altered_metastatic_potential | 0.95488749 |
84 | MP0005645_abnormal_hypothalamus_physiol | 0.95300980 |
85 | MP0000920_abnormal_myelination | 0.94634489 |
86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93464099 |
87 | MP0001881_abnormal_mammary_gland | 0.93230120 |
88 | MP0001663_abnormal_digestive_system | 0.92579279 |
89 | MP0009763_increased_sensitivity_to | 0.92321441 |
90 | MP0009765_abnormal_xenobiotic_induced | 0.92131078 |
91 | MP0003183_abnormal_peptide_metabolism | 0.88751647 |
92 | MP0005023_abnormal_wound_healing | 0.88700819 |
93 | MP0005319_abnormal_enzyme/_coenzyme | 0.88593938 |
94 | MP0002118_abnormal_lipid_homeostasis | 0.88269871 |
95 | MP0005167_abnormal_blood-brain_barrier | 0.88264839 |
96 | MP0005390_skeleton_phenotype | 0.87377295 |
97 | MP0004264_abnormal_extraembryonic_tissu | 0.85961312 |
98 | MP0002998_abnormal_bone_remodeling | 0.84314667 |
99 | MP0003075_altered_response_to | 0.83672679 |
100 | MP0005381_digestive/alimentary_phenotyp | 0.82988591 |
101 | MP0005164_abnormal_response_to | 0.82627184 |
102 | MP0001216_abnormal_epidermal_layer | 0.80667903 |
103 | MP0005451_abnormal_body_composition | 0.80116176 |
104 | MP0002396_abnormal_hematopoietic_system | 0.80001118 |
105 | MP0005636_abnormal_mineral_homeostasis | 0.79637179 |
106 | MP0005165_increased_susceptibility_to | 0.79144662 |
107 | MP0001346_abnormal_lacrimal_gland | 0.77387964 |
108 | MP0010678_abnormal_skin_adnexa | 0.77026844 |
109 | MP0004883_abnormal_blood_vessel | 0.74730815 |
110 | MP0005084_abnormal_gallbladder_morpholo | 0.74544966 |
111 | MP0001545_abnormal_hematopoietic_system | 0.74053065 |
112 | MP0005397_hematopoietic_system_phenotyp | 0.74053065 |
113 | MP0003448_altered_tumor_morphology | 0.72524450 |
114 | MP0000249_abnormal_blood_vessel | 0.72498092 |
115 | MP0004782_abnormal_surfactant_physiolog | 0.72448947 |
116 | MP0001764_abnormal_homeostasis | 0.71853094 |
117 | MP0001765_abnormal_ion_homeostasis | 0.70966809 |
118 | MP0005075_abnormal_melanosome_morpholog | 0.70177104 |
119 | MP0000598_abnormal_liver_morphology | 0.69979173 |
120 | MP0000477_abnormal_intestine_morphology | 0.69433715 |
121 | MP0002019_abnormal_tumor_incidence | 0.68422412 |
122 | MP0003186_abnormal_redox_activity | 0.67527137 |
123 | MP0002837_dystrophic_cardiac_calcinosis | 0.66621329 |
124 | MP0002693_abnormal_pancreas_physiology | 0.62792236 |
125 | MP0002095_abnormal_skin_pigmentation | 0.60970905 |
126 | MP0003045_fibrosis | 0.55961627 |
127 | MP0003638_abnormal_response/metabolism_ | 0.55570268 |
128 | MP0003795_abnormal_bone_structure | 0.53951230 |
129 | MP0006036_abnormal_mitochondrial_physio | 0.52544306 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 3.96158560 |
2 | Agammaglobulinemia (HP:0004432) | 3.87312045 |
3 | Mediastinal lymphadenopathy (HP:0100721) | 3.82899809 |
4 | Chronic otitis media (HP:0000389) | 3.80905442 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76983555 |
6 | Petechiae (HP:0000967) | 3.61392289 |
7 | Abnormality of T cell number (HP:0011839) | 3.53223452 |
8 | Myositis (HP:0100614) | 3.52594105 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.48793428 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.48793428 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.48793428 |
12 | Abnormal number of erythroid precursors (HP:0012131) | 3.43440021 |
13 | T lymphocytopenia (HP:0005403) | 3.40645989 |
14 | Nasal polyposis (HP:0100582) | 3.36683028 |
15 | Recurrent fungal infections (HP:0002841) | 3.27328226 |
16 | Recurrent sinusitis (HP:0011108) | 3.21504979 |
17 | Stomatitis (HP:0010280) | 3.21241774 |
18 | Abnormality of the nasal mucosa (HP:0000433) | 3.14445897 |
19 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.12832025 |
20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.07417171 |
21 | Orchitis (HP:0100796) | 3.05279114 |
22 | Pustule (HP:0200039) | 3.02798355 |
23 | Recurrent bronchitis (HP:0002837) | 2.95273663 |
24 | Autoimmune thrombocytopenia (HP:0001973) | 2.92817468 |
25 | Obstructive lung disease (HP:0006536) | 2.91462677 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91462677 |
27 | Retrobulbar optic neuritis (HP:0100654) | 2.90794638 |
28 | Optic neuritis (HP:0100653) | 2.90794638 |
29 | Cellulitis (HP:0100658) | 2.88256963 |
30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81084711 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81084711 |
32 | Abnormality of T cells (HP:0002843) | 2.79210410 |
33 | IgM deficiency (HP:0002850) | 2.78751710 |
34 | Interstitial pulmonary disease (HP:0006530) | 2.78662859 |
35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75320491 |
36 | Chronic diarrhea (HP:0002028) | 2.73991603 |
37 | Joint swelling (HP:0001386) | 2.72259779 |
38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.66425200 |
39 | Vasculitis (HP:0002633) | 2.65901412 |
40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63192993 |
41 | Mitochondrial inheritance (HP:0001427) | 2.63152262 |
42 | Keratoconjunctivitis (HP:0001096) | 2.62480597 |
43 | Recurrent viral infections (HP:0004429) | 2.61860601 |
44 | Acute necrotizing encephalopathy (HP:0006965) | 2.61640062 |
45 | Xanthomatosis (HP:0000991) | 2.61135341 |
46 | Increased IgE level (HP:0003212) | 2.60661033 |
47 | Recurrent skin infections (HP:0001581) | 2.60177088 |
48 | Deep venous thrombosis (HP:0002625) | 2.59356657 |
49 | Persistence of primary teeth (HP:0006335) | 2.57284628 |
50 | Intrahepatic cholestasis (HP:0001406) | 2.56937523 |
51 | Abnormality of macrophages (HP:0004311) | 2.56389671 |
52 | Severe combined immunodeficiency (HP:0004430) | 2.55892269 |
53 | Prolonged bleeding time (HP:0003010) | 2.51972539 |
54 | Purpura (HP:0000979) | 2.50188671 |
55 | Autoimmune hemolytic anemia (HP:0001890) | 2.48422306 |
56 | Combined immunodeficiency (HP:0005387) | 2.47912516 |
57 | Myocardial infarction (HP:0001658) | 2.45820742 |
58 | Inflammation of the large intestine (HP:0002037) | 2.45625141 |
59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.44885406 |
60 | Abnormality of T cell physiology (HP:0011840) | 2.44595038 |
61 | Chronic sinusitis (HP:0011109) | 2.42732054 |
62 | Gastrointestinal infarctions (HP:0005244) | 2.39469974 |
63 | Increased density of long bones (HP:0006392) | 2.38932753 |
64 | Spontaneous hematomas (HP:0007420) | 2.38273190 |
65 | Restrictive lung disease (HP:0002091) | 2.37684005 |
66 | Pulmonary embolism (HP:0002204) | 2.37599188 |
67 | B lymphocytopenia (HP:0010976) | 2.37086539 |
68 | Gastrointestinal stroma tumor (HP:0100723) | 2.36956131 |
69 | Abnormality of B cell number (HP:0010975) | 2.36555574 |
70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.33681834 |
71 | Keratoconjunctivitis sicca (HP:0001097) | 2.33497636 |
72 | Gastrointestinal inflammation (HP:0004386) | 2.33323091 |
73 | Panhypogammaglobulinemia (HP:0003139) | 2.33147835 |
74 | Recurrent abscess formation (HP:0002722) | 2.32679839 |
75 | Arterial thrombosis (HP:0004420) | 2.32085591 |
76 | Recurrent bacterial skin infections (HP:0005406) | 2.31507350 |
77 | Colitis (HP:0002583) | 2.31364914 |
78 | Vacuolated lymphocytes (HP:0001922) | 2.30607670 |
79 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30460019 |
80 | Skin rash (HP:0000988) | 2.29052473 |
81 | Abnormality of proline metabolism (HP:0010907) | 2.28449158 |
82 | Hydroxyprolinuria (HP:0003080) | 2.28449158 |
83 | Gingival bleeding (HP:0000225) | 2.27047891 |
84 | Increased muscle lipid content (HP:0009058) | 2.26392938 |
85 | Hepatocellular necrosis (HP:0001404) | 2.24711330 |
86 | Axonal loss (HP:0003447) | 2.22813214 |
87 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22447385 |
88 | Acute encephalopathy (HP:0006846) | 2.21888143 |
89 | Hypertensive crisis (HP:0100735) | 2.20860451 |
90 | Hepatic necrosis (HP:0002605) | 2.20126395 |
91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18860179 |
92 | Abnormality of the prostate (HP:0008775) | 2.18423987 |
93 | Increased intramyocellular lipid droplets (HP:0012240) | 2.17644244 |
94 | Pulmonary infiltrates (HP:0002113) | 2.16745075 |
95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15635042 |
96 | Recurrent pneumonia (HP:0006532) | 2.12087991 |
97 | Progressive macrocephaly (HP:0004481) | 2.09919400 |
98 | Esophageal varix (HP:0002040) | 2.09874136 |
99 | Fatigue (HP:0012378) | 2.08802621 |
100 | Exertional dyspnea (HP:0002875) | 2.08329374 |
101 | Hypokalemic alkalosis (HP:0001949) | 2.06193571 |
102 | Abnormality of eosinophils (HP:0001879) | 2.05610782 |
103 | IgA deficiency (HP:0002720) | 2.04092605 |
104 | Vascular calcification (HP:0004934) | 2.04062794 |
105 | Leukocytosis (HP:0001974) | 2.03790199 |
106 | Neutropenia (HP:0001875) | 2.02700172 |
107 | Dysostosis multiplex (HP:0000943) | 2.02566886 |
108 | Encephalitis (HP:0002383) | 2.02558042 |
109 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.02538481 |
110 | Eosinophilia (HP:0001880) | 2.01970561 |
111 | Hypergammaglobulinemia (HP:0010702) | 2.01856919 |
112 | Hemoptysis (HP:0002105) | 2.01508856 |
113 | Increased serum ferritin (HP:0003281) | 2.01384612 |
114 | Aplastic anemia (HP:0001915) | 2.01199323 |
115 | Generalized aminoaciduria (HP:0002909) | 2.01034696 |
116 | Abnormal pupillary function (HP:0007686) | 2.00615922 |
117 | Papilloma (HP:0012740) | 1.99554569 |
118 | Verrucae (HP:0200043) | 1.99554569 |
119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99228934 |
120 | Hepatosplenomegaly (HP:0001433) | 1.98373523 |
121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.97971119 |
122 | Dicarboxylic aciduria (HP:0003215) | 1.97971119 |
123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97272269 |
124 | Lymphopenia (HP:0001888) | 1.96788692 |
125 | Abnormality of iron homeostasis (HP:0011031) | 1.96654486 |
126 | Systemic lupus erythematosus (HP:0002725) | 1.96452816 |
127 | Increased CSF lactate (HP:0002490) | 1.96296840 |
128 | Meningitis (HP:0001287) | 1.95613479 |
129 | Thrombophlebitis (HP:0004418) | 1.95343074 |
130 | Increased IgM level (HP:0003496) | 1.94927061 |
131 | Fat malabsorption (HP:0002630) | 1.94194724 |
132 | Urticaria (HP:0001025) | 1.94179395 |
133 | Abnormality of the pleura (HP:0002103) | 1.92502370 |
134 | Epistaxis (HP:0000421) | 1.92132347 |
135 | Increased cerebral lipofuscin (HP:0011813) | 1.90296528 |
136 | IgG deficiency (HP:0004315) | 1.88508909 |
137 | Complement deficiency (HP:0004431) | 1.88218191 |
138 | Amyloidosis (HP:0011034) | 1.87974756 |
139 | Polycythemia (HP:0001901) | 1.87390704 |
140 | Abnormal platelet function (HP:0011869) | 1.85349095 |
141 | Impaired platelet aggregation (HP:0003540) | 1.85349095 |
142 | Granulocytopenia (HP:0001913) | 1.84264560 |
143 | Abnormality of chloride homeostasis (HP:0011422) | 1.84150930 |
144 | Metabolic alkalosis (HP:0200114) | 1.83846933 |
145 | Ileus (HP:0002595) | 1.81914561 |
146 | Thrombocytosis (HP:0001894) | 1.80989855 |
147 | Emphysema (HP:0002097) | 1.80480472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.15175256 |
2 | VRK2 | 3.46361226 |
3 | EPHB1 | 3.34149081 |
4 | TXK | 3.15225513 |
5 | MAP3K14 | 3.14796167 |
6 | FGFR4 | 3.14590667 |
7 | RIPK4 | 2.65714489 |
8 | JAK3 | 2.50204893 |
9 | TYK2 | 2.47242499 |
10 | TBK1 | 2.46476732 |
11 | ZAP70 | 2.34272802 |
12 | ITK | 2.33934450 |
13 | MST4 | 2.33828694 |
14 | IKBKE | 2.12916976 |
15 | STK10 | 2.09099600 |
16 | ERN1 | 2.05515466 |
17 | VRK1 | 1.98262159 |
18 | JAK1 | 1.98243471 |
19 | TLK1 | 1.88660975 |
20 | TAOK3 | 1.79633539 |
21 | EPHA3 | 1.74692721 |
22 | TRIB3 | 1.74272587 |
23 | IKBKB | 1.67691999 |
24 | LRRK2 | 1.66968094 |
25 | GRK6 | 1.54303452 |
26 | CSK | 1.54214858 |
27 | PTK6 | 1.53893632 |
28 | SIK1 | 1.49218851 |
29 | ADRBK2 | 1.47647018 |
30 | IRAK3 | 1.44045755 |
31 | NLK | 1.42967399 |
32 | BTK | 1.42192810 |
33 | TAOK2 | 1.40515378 |
34 | KIT | 1.38991569 |
35 | TGFBR2 | 1.36726015 |
36 | GRK7 | 1.31520758 |
37 | CHUK | 1.27236127 |
38 | EEF2K | 1.26812061 |
39 | MAP3K3 | 1.25725801 |
40 | FES | 1.25673183 |
41 | LCK | 1.24516537 |
42 | MAP2K3 | 1.21738602 |
43 | MAP3K13 | 1.18987985 |
44 | TEC | 1.17880257 |
45 | FGFR3 | 1.16809403 |
46 | TNK2 | 1.14136221 |
47 | MAPK15 | 1.12968891 |
48 | TESK2 | 1.11157740 |
49 | KDR | 1.10526920 |
50 | SYK | 1.06827195 |
51 | MAP3K7 | 1.06288686 |
52 | JAK2 | 1.04421358 |
53 | CSF1R | 1.03339266 |
54 | CCNB1 | 1.00811448 |
55 | BLK | 1.00184859 |
56 | HCK | 0.99625601 |
57 | DAPK2 | 0.98960906 |
58 | STK39 | 0.98696055 |
59 | MAP2K2 | 0.97726640 |
60 | PRKCQ | 0.94606125 |
61 | BMPR2 | 0.93768563 |
62 | BCKDK | 0.92509982 |
63 | MST1R | 0.90689170 |
64 | NUAK1 | 0.87949911 |
65 | WNK4 | 0.87882715 |
66 | DAPK3 | 0.87443122 |
67 | ARAF | 0.86431435 |
68 | PRPF4B | 0.83281703 |
69 | ABL2 | 0.83265516 |
70 | MUSK | 0.83018514 |
71 | MAP3K10 | 0.82226004 |
72 | PKN2 | 0.81917232 |
73 | MOS | 0.80725152 |
74 | TRPM7 | 0.78090574 |
75 | IRAK4 | 0.77118752 |
76 | PASK | 0.77010565 |
77 | MAPKAPK3 | 0.75526560 |
78 | FGR | 0.74995582 |
79 | PRKCH | 0.70701684 |
80 | PIM1 | 0.67863484 |
81 | MAP4K2 | 0.67066179 |
82 | PRKG2 | 0.64682358 |
83 | MARK3 | 0.63388266 |
84 | NME1 | 0.63220008 |
85 | RPS6KA4 | 0.61446172 |
86 | MAP3K11 | 0.60960835 |
87 | PIM2 | 0.59175674 |
88 | MAPKAPK2 | 0.58518961 |
89 | LYN | 0.58295143 |
90 | ZAK | 0.56791363 |
91 | PKN1 | 0.56518038 |
92 | NME2 | 0.56049166 |
93 | TESK1 | 0.55812565 |
94 | STK16 | 0.55623181 |
95 | PIK3CG | 0.55483288 |
96 | GSK3A | 0.54730411 |
97 | TGFBR1 | 0.54441470 |
98 | FLT3 | 0.54129627 |
99 | MAP3K1 | 0.53640818 |
100 | PRKCD | 0.52234460 |
101 | PDGFRB | 0.51372976 |
102 | MAP3K2 | 0.51227717 |
103 | OXSR1 | 0.51221762 |
104 | PTK2 | 0.50854350 |
105 | EPHB2 | 0.50457494 |
106 | MAPKAPK5 | 0.48598997 |
107 | DAPK1 | 0.48526189 |
108 | IRAK1 | 0.48476080 |
109 | MET | 0.47341474 |
110 | GRK5 | 0.45911297 |
111 | MAPK11 | 0.45352074 |
112 | RIPK1 | 0.42802739 |
113 | TAOK1 | 0.42163092 |
114 | ADRBK1 | 0.41750255 |
115 | MAP3K8 | 0.41220407 |
116 | GRK1 | 0.40534177 |
117 | FGFR2 | 0.40194385 |
118 | MATK | 0.40164078 |
119 | INSR | 0.39690961 |
120 | RET | 0.39125851 |
121 | SMG1 | 0.38464898 |
122 | CLK1 | 0.38037243 |
123 | FRK | 0.37327653 |
124 | AURKA | 0.35933995 |
125 | PDK1 | 0.35030535 |
126 | MAP2K6 | 0.34962700 |
127 | BMX | 0.34903101 |
128 | RPS6KA6 | 0.34204862 |
129 | MAP3K5 | 0.33601560 |
130 | IGF1R | 0.33457239 |
131 | MAPK7 | 0.33087478 |
132 | MAPK4 | 0.32307257 |
133 | ABL1 | 0.31873109 |
134 | RPS6KC1 | 0.30763498 |
135 | RPS6KL1 | 0.30763498 |
136 | HIPK2 | 0.30706802 |
137 | LIMK1 | 0.30276363 |
138 | RPS6KA5 | 0.30270765 |
139 | EGFR | 0.30179603 |
140 | FYN | 0.28726615 |
141 | NEK9 | 0.27493652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09075086 |
2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.94155914 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63536014 |
4 | Ribosome_Homo sapiens_hsa03010 | 2.42595917 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22818133 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.14546275 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.13307930 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04257882 |
9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.03698487 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88649057 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88358151 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.82317690 |
13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.78420125 |
14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76705056 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76402803 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74980502 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70586546 |
18 | Measles_Homo sapiens_hsa05162 | 1.67104704 |
19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64297957 |
20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.62185648 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56843684 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52312242 |
23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.50633038 |
24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49077049 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48080492 |
26 | Proteasome_Homo sapiens_hsa03050 | 1.43354036 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42310634 |
28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38529596 |
29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35139899 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34405923 |
31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31152976 |
32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28770228 |
33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27053703 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26131565 |
35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25733442 |
36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25576384 |
37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22808383 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21136786 |
39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19681408 |
40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17479787 |
41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16271386 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.16249574 |
43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.15378603 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13663603 |
45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12672257 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11330998 |
47 | Phagosome_Homo sapiens_hsa04145 | 1.08695707 |
48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07852231 |
49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07128652 |
50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04842396 |
51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03601708 |
52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03164867 |
53 | Malaria_Homo sapiens_hsa05144 | 1.03080309 |
54 | Legionellosis_Homo sapiens_hsa05134 | 1.02679520 |
55 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00257769 |
56 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99910138 |
57 | Huntingtons disease_Homo sapiens_hsa05016 | 0.98403990 |
58 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97227609 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.96117222 |
60 | Pertussis_Homo sapiens_hsa05133 | 0.95461472 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93820312 |
62 | Influenza A_Homo sapiens_hsa05164 | 0.92983725 |
63 | Peroxisome_Homo sapiens_hsa04146 | 0.92029316 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90976008 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90399422 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.90381159 |
67 | Apoptosis_Homo sapiens_hsa04210 | 0.89005448 |
68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88352003 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88349863 |
70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.87413106 |
71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87240461 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87196093 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86946812 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86716958 |
75 | Bile secretion_Homo sapiens_hsa04976 | 0.85411951 |
76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85381135 |
77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84781982 |
78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84687316 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84196339 |
80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.78530431 |
81 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78250806 |
82 | Lysosome_Homo sapiens_hsa04142 | 0.77717697 |
83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77168888 |
84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74226932 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73652395 |
86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71737273 |
87 | Homologous recombination_Homo sapiens_hsa03440 | 0.71623325 |
88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71283870 |
89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71223339 |
90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70321773 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69814637 |
92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69113903 |
93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68335893 |
94 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68335392 |
95 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67798658 |
96 | Tuberculosis_Homo sapiens_hsa05152 | 0.67449935 |
97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65697010 |
98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65090081 |
99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64479899 |
100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64469049 |
101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64221225 |
102 | Hepatitis B_Homo sapiens_hsa05161 | 0.63914238 |
103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63355492 |
104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63300939 |
105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.60984854 |
106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60771501 |
107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.60412299 |
108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60190505 |
109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58897678 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58042872 |
111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58039746 |
112 | Asthma_Homo sapiens_hsa05310 | 0.57770891 |
113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57726705 |
114 | Base excision repair_Homo sapiens_hsa03410 | 0.56742007 |
115 | DNA replication_Homo sapiens_hsa03030 | 0.56492669 |
116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56193480 |
117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56106509 |
118 | Salmonella infection_Homo sapiens_hsa05132 | 0.56004949 |
119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55349163 |
120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55059911 |
121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54143294 |
122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51127591 |
123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50569653 |
124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49893735 |
125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49884350 |
126 | Insulin resistance_Homo sapiens_hsa04931 | 0.48411466 |
127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46223838 |
128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45393351 |
129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45247942 |
130 | Mineral absorption_Homo sapiens_hsa04978 | 0.45097091 |
131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43220201 |
132 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41729429 |
133 | RNA polymerase_Homo sapiens_hsa03020 | 0.40094282 |
134 | Mismatch repair_Homo sapiens_hsa03430 | 0.39750366 |
135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38120199 |
136 | Protein export_Homo sapiens_hsa03060 | 0.30887716 |
137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30718022 |
138 | Platelet activation_Homo sapiens_hsa04611 | 0.24832976 |
139 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24566984 |
140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.20798350 |
141 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16805347 |
142 | Purine metabolism_Homo sapiens_hsa00230 | 0.16770150 |
143 | Bladder cancer_Homo sapiens_hsa05219 | 0.16382000 |
144 | Alcoholism_Homo sapiens_hsa05034 | 0.15511692 |